448 related articles for article (PubMed ID: 31802357)
21. The Prognostic Impact of Radiotherapy in Conjunction with Temozolomide in Diffuse Intrinsic Pontine Glioma: A Systematic Review and Meta-Analysis.
Shi S; Lu S; Jing X; Liao J; Li Q
World Neurosurg; 2021 Apr; 148():e565-e571. PubMed ID: 33476781
[TBL] [Abstract][Full Text] [Related]
22. Very Long-term Survivorship in Pediatric DIPG: Case Report and Review of the Literature.
Dimentberg E; Marceau MP; Lachance A; Bergeron-Gravel S; Saikali S; Crevier L; Bourget C; Hawkins C; Jabado N; Giannakouros P; Renzi S; Larouche V
J Pediatr Hematol Oncol; 2024 May; 46(4):211-215. PubMed ID: 38573000
[TBL] [Abstract][Full Text] [Related]
23. A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Su JM; Murray JC; McNall-Knapp RY; Bowers DC; Shah S; Adesina AM; Paulino AC; Jo E; Mo Q; Baxter PA; Blaney SM
Pediatr Blood Cancer; 2020 Jun; 67(6):e28283. PubMed ID: 32285998
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma.
Hashizume R
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):331-342. PubMed ID: 28592748
[TBL] [Abstract][Full Text] [Related]
25. Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.
Hennika T; Becher OJ
J Child Neurol; 2016 Oct; 31(12):1377-85. PubMed ID: 26374787
[TBL] [Abstract][Full Text] [Related]
26. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models.
Martinez-Velez N; Marigil M; García-Moure M; Gonzalez-Huarriz M; Aristu JJ; Ramos-García LI; Tejada S; Díez-Valle R; Patiño-García A; Becher OJ; Gomez-Manzano C; Fueyo J; Alonso MM
Acta Neuropathol Commun; 2019 Apr; 7(1):64. PubMed ID: 31036068
[TBL] [Abstract][Full Text] [Related]
27. Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.
Valvi S; Manoharan N; Mateos MK; Hassall TE; Ziegler DS; McCowage GB; Dun MD; Eisenstat DD; Gottardo NG; Hansford JR
Med J Aust; 2024 Jun; 220(10):533-538. PubMed ID: 38699949
[TBL] [Abstract][Full Text] [Related]
28. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.
Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM
J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807
[TBL] [Abstract][Full Text] [Related]
29. Diffuse intrinsic pontine gliomas: treatments and controversies.
Bredlau AL; Korones DN
Adv Cancer Res; 2014; 121():235-259. PubMed ID: 24889533
[TBL] [Abstract][Full Text] [Related]
30. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
[TBL] [Abstract][Full Text] [Related]
31. A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas.
Hipp SJ; Goldman S; Kaushal A; Krauze A; Citrin D; Glod J; Walker K; Shih JH; Sethumadhavan H; O'Neill K; Garvin JH; Glade-Bender J; Karajannis MA; Atlas MP; Odabas A; Rodgers LT; Peer CJ; Savage J; Camphausen KA; Packer RJ; Figg WD; Warren KE
J Neurooncol; 2020 Sep; 149(3):437-445. PubMed ID: 33040274
[TBL] [Abstract][Full Text] [Related]
32. Laminin-associated integrins mediate Diffuse Intrinsic Pontine Glioma infiltration and therapy response within a neural assembloid model.
Sinha S; Huang MS; Mikos G; Bedi Y; Soto L; Lensch S; Ayushman M; Bintu L; Bhutani N; Heilshorn SC; Yang F
Acta Neuropathol Commun; 2024 May; 12(1):71. PubMed ID: 38706008
[TBL] [Abstract][Full Text] [Related]
33. Treatment options for paediatric brainstem gliomas.
Khan DA; Laghari AA; Bari ME; Shamim MS
J Pak Med Assoc; 2019 Sep; 69(9):1400-1402. PubMed ID: 31511736
[TBL] [Abstract][Full Text] [Related]
34. Suggestions for Escaping the Dark Ages for Pediatric Diffuse Intrinsic Pontine Glioma Treated with Radiotherapy: Analysis of Prognostic Factors from the National Multicenter Study.
Kim HJ; Lee JH; Kim Y; Lim DH; Park SH; Ahn SD; Kim IA; Im JH; Chung JW; Kim JY; Kim IH; Yoon HI; Suh CO
Cancer Res Treat; 2023 Jan; 55(1):41-49. PubMed ID: 35255651
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
Lu VM; Welby JP; Mahajan A; Laack NN; Daniels DJ
Childs Nerv Syst; 2019 May; 35(5):739-746. PubMed ID: 30879125
[TBL] [Abstract][Full Text] [Related]
36. Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas.
Puget S; Beccaria K; Blauwblomme T; Roujeau T; James S; Grill J; Zerah M; Varlet P; Sainte-Rose C
Childs Nerv Syst; 2015 Oct; 31(10):1773-80. PubMed ID: 26351229
[TBL] [Abstract][Full Text] [Related]
37. Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
Zamora PL; Miller SR; Kovoor JJ
Childs Nerv Syst; 2021 Aug; 37(8):2539-2543. PubMed ID: 33973056
[TBL] [Abstract][Full Text] [Related]
38. Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets.
Johung TB; Monje M
Curr Neuropharmacol; 2017; 15(1):88-97. PubMed ID: 27157264
[TBL] [Abstract][Full Text] [Related]
39. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
Zhang L; Yu H; Xue Y; Liu Y
Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
[TBL] [Abstract][Full Text] [Related]
40. Management of diffuse intrinsic pontine glioma in children: current and future strategies for improving prognosis.
Kaye EC; Baker JN; Broniscer A
CNS Oncol; 2014 Nov; 3(6):421-31. PubMed ID: 25438813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]